AbbVie Inc (NYSE:ABBV)

Monday’s trading has closed, but ABBV is being traded in the after-hours session. After-Hours quote »
Data as of 4:00pm ET
 +0.42 / +0.62%
Today’s Change
Today|||52-Week Range
Sanofi's (SNY) Cerdelga a Step Closer to European Approval - Analyst Blog
5:19pm /
Stocks 20 Billionaires Loved and Hated in the Third Quarter
Nov 17 /
3 Biotech Stocks That Could Soar Even Higher
3:45pm /
3 Stocks Moving The Drugs Industry Upward
Nov 17 /
Low Interest Rates, Gas Prices to Fuel Stock Market Gains in 2015
2:41pm /
Cramer: Pfizer Deal With Merck Leaves AstraZeneca In the Cold
Nov 17 /
Today AbbVie (ABBV) Hits New Lifetime High
10:08am /
Stocks Hitting 52-Week Highs
Nov 17 / Benzinga
Notable Analyst Rating Changes 11/7: (CA) (GNC) (SPLK) Upgraded; (OXY) (ABBV) (SLXP) ...
Nov 23 / Investing Channel
Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
Nov 17 /
George Soros Just Bought These 3 Stocks: Should You?
Nov 23 /
7 Biggest Health Problems Americans Face
Nov 16 /
Can New Launches Offset Sanofi's Soft Diabetes Business? - Analyst Blog
Nov 21 /
AbbVie Inc. vs. Pfizer Inc.: Which Is the Better Dividend Stock?
Nov 16 /
Amgen and AbbVie Strengthen Manufacturing Facilities in Asia - Analyst Blog
Nov 21 /
Where Will Google Stock Be in 10 Years?
Nov 14 /
Buy Gilead Sciences
Nov 21 /
Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog
Nov 12 /
J&J Seeks FDA Approval for Schizophrenia Treatment - Analyst Blog
Nov 20 /
Regeneron/Sanofi Announce Positive Dupilumab Study Data - Analyst Blog
Nov 12 /
Shire to Relocate Employees Under One Shire Program - Analyst Blog
Nov 20 /
Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bank...
Nov 12 /
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog
Nov 19 /
Bristol-Myers Gives Updates on HCV Candidate Daclatasvir - Analyst Blog
Nov 11 /
AstraZeneca Targets More than $45B in Revenues in 2023 - Analyst Blog
Nov 19 /
Stock Market News for November 11, 2014 - Market News
Nov 11 /
Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews
Nov 19 /
Repros Soars on Positive FDA Meeting Regarding Androxa - Analyst Blog
Nov 10 /
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
Nov 19 /
Merck Reports Interim Data on Hepatitis C Virus Drug - Analyst Blog
Nov 10 /
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in th...
Nov 19 /
Emergent BioSolutions Beats on Q3 Earnings, Guidance Up - Analyst Blog
Nov 10 /
Celldex Therapeutics Surges on Positive Rindopepimut Data - Analyst Blog
Nov 18 /
Bets gone awry push Paulson fund to loss
Nov 10 /
Roche's (RHHBY) Avastin Label Expansion Approved by FDA - Analyst Blog
Nov 18 /
Bill Ackman wins Allergan insider trading lawsuit
Nov 04 /
Novartis Presents Data on Heart Failure Candidate LCZ696 - Analyst Blog
Nov 18 /
Aggressive tax avoidance troubles large investors
Nov 02 /
Merck Updates on Anti-PD-1 Drug Keytruda Phase II Study - Analyst Blog
Nov 17 /
Pfizer chief: tax inversions still have "meaningful value"
Oct 28 /
Jim Cramer Answers Twitter (TWTR) Questions on Gold, Gilead and More
Nov 17 /
The Silver Economy: Silicon Valley joins quest to 'cure' ageing
Oct 26 /

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.